Invesco Ltd. Glaukos Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Invesco Ltd. holds 1,390,325 shares of GKOS stock, worth $200 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,390,325

Previous 1,614,719 13.9%

Holding current value

$200 Million

Previous $191 Million 5.22%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$113.62 - $135.39 $25.5 Million - $30.4 Million	-224,394 Reduced 13.9%	1,390,325 $181 Million
Q2 2024 Aug 13, 2024	BUY	$89.48 - $118.35 $945,177 - $1.25 Million	10,563 Added 0.66%	1,614,719 $191 Million
Q1 2024 May 14, 2024	BUY	$76.4 - $96.33 $2.41 Million - $3.04 Million	31,541 Added 2.01%	1,604,156 $151 Million
Q4 2023 Feb 12, 2024	BUY	$59.53 - $85.11 $7.3 Million - $10.4 Million	122,582 Added 8.45%	1,572,615 $125 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $31.4 Million - $35.9 Million	453,756 Added 45.55%	1,450,033 $109 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $35.6 Million - $55.8 Million	783,169 Added 367.5%	996,277 $70.9 Million
Q1 2023 May 12, 2023	SELL	$43.88 - $52.48 $371,619 - $444,453	-8,469 Reduced 3.82%	213,108 $10.7 Million
Q4 2022 Feb 13, 2023	BUY	$40.82 - $57.75 $437,631 - $619,137	10,721 Added 5.08%	221,577 $9.68 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $218,414 - $272,738	4,663 Added 2.26%	210,856 $11.2 Million
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $394,162 - $721,047	-11,307 Reduced 5.2%	206,193 $9.37 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $197,756 - $257,935	-4,461 Reduced 2.01%	217,500 $12.6 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $478,528 - $677,212	-11,883 Reduced 5.08%	221,961 $9.86 Million
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $491,327 - $872,538	-10,359 Reduced 4.24%	233,844 $11.3 Million
Q2 2021 Aug 17, 2021	SELL	$73.06 - $97.7 $5.91 Million - $7.9 Million	-80,878 Reduced 24.88%	244,203 $20.7 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $6.33 Million - $8.75 Million	89,858 Added 38.2%	325,081 $27.3 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $283,424 - $436,206	-5,796 Reduced 2.4%	235,223 $17.7 Million
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $648,583 - $887,948	17,421 Added 7.79%	241,019 $11.9 Million
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $107,406 - $174,769	3,732 Added 1.7%	223,598 $8.59 Million
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $9.52 Million - $26.2 Million	-372,973 Reduced 62.91%	219,866 $6.79 Million
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $13.9 Million - $16.8 Million	-255,965 Reduced 30.16%	592,839 $32.3 Million
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $11.9 Million - $17.1 Million	203,401 Added 31.52%	848,804 $53.1 Million
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $2.6 Million - $3.21 Million	-40,839 Reduced 5.95%	645,403 $48.7 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $30.8 Million - $48.9 Million	607,440 Added 770.84%	686,242 $53.8 Million
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $4.11 Million - $5.35 Million	78,802 New	78,802 $4.43 Million

Others Institutions Holding GKOS

# of Institutions

340

Shares Held

47.1M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account